Welcome to the News Room

Pugatch Consilium releases new report on National Biotechnology Innovation strategies

Posted by:

Today Pugatch Consilium releases a new report on the development of national innovation strategies in the biotech sector commissioned by the Biotechnology Industry Organization (BIO).

The report, Building the Bioeconomy Examining National Biotechnology Industry Development Strategies, provides an overview of national innovation strategies, policies and best practices that relate to the building of a world-class biotechnology sector. It identifies key enabling policy input factors ranging from human capital, protection of intellectual property to infrastructure for research and development.

Through case study analysis the paper focuses on the biotechnology strategies of a sample of eight countries. The countries mapped are Brazil, China, India, Korea, Russia, Singapore, Switzerland and the United States. The point of reference for this overview is the development of a globally competitive biotech sector in which local biotech actors and stakeholders aim to and can compete globally.

Download a copy from the Research & Analysis Reports page.

For further information please contact Dr David Torstensson Email David


About the Author:

David’s focus is policy and economic analysis related to innovation, health care, pharmaceuticals, tax and intellectual property. He has wide experience in quantitative research methods including index-building and data sampling and is the author of a number of both academic and commissioned publications. David’s knowledge spans from North America and Europe to the BRIC economies, and he speaks fluent Swedish. Prior to his work with Pugatch Consilium, David was with Deloitte LLP where he worked on a broad range of UK and international tax compliance and advisory projects. David holds a Master of Studies and DPhil (PhD) from Oxford University.
  Related Posts
  • No related posts found.